Shoko Kinoshita
Takatsuki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pattern of Expression of MicroRNA in Patients with Radiation-Induced Bladder Injury.
Journal: Oncology
Published: November 04, 2023
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Journal: Molecular cancer
Published: August 31, 2023
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
Journal: World journal of urology
Published: May 30, 2023
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.
Journal: Cancer diagnosis & prognosis
Published: February 10, 2023
Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
Journal: In vivo (Athens, Greece)
Published: October 08, 2022
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer.
Journal: Journal for immunotherapy of cancer
Published: December 07, 2021
Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.
Journal: Urologic oncology
Published: October 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026